254.37

1.54% 3.86

Labcorp Holdings Inc (LH)

Overview News Price History Option Chain Financials Why LH Down? Discussions Forecast Stock Split Dividend History

Labcorp Holdings Inc stock is traded at $254.37, with a volume of 892.61K. It is up +1.54% in the last 24 hours and up +2.71% over the past month. Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Previous Close:

$250.51

Open:

$251.35

24h Volume:

892.61K

Relative Volume:

1.13

Market Cap:

$21.29B

Revenue:

$12.71B

Net Income/Loss:

$435.50M

P/E Ratio:

49.39

EPS:

5.15

Net Cash Flow:

$843.20M

1W Performance:

+2.97%

1M Performance:

+2.71%

6M Performance:

+7.15%

1Y Performance:

+29.33%

1-Day Range:

$250.52

$254.85

1-Week Range:

$243.71

$254.85

52-Week Range:

$192.38

$258.59

Labcorp Holdings Inc Stock (LH) Company Profile

Name

Labcorp Holdings Inc

Sector

Healthcare (1170)

Industry

Diagnostics & Research (56)

Phone

(336) 229-1127

Address

358 S MAIN ST, BURLINGTON, NC

Employee

70,000

Twitter

@labcorp

Next Earnings Date

2024-10-24

Latest SEC Filings

LH's Discussions on Twitter

Compare LH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LH Labcorp Holdings Inc	254.37	20.68B	12.71B	435.50M	843.20M	5.15
TMO Thermo Fisher Scientific Inc	403.66	151.80B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	193.08	135.27B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	524.86	41.36B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	114.94	31.50B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	147.90	24.01B	15.50B	1.33B	2.16B	7.34

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-02-25	Initiated	Redburn Atlantic	Buy
Mar-04-25	Upgrade	Citigroup	Neutral → Buy
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Dec-10-24	Resumed	Jefferies	Buy
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral
Mar-25-24	Upgrade	Argus	Hold → Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Initiated	Evercore ISI	In-line
Jan-03-24	Initiated	Barclays	Equal Weight
Sep-06-23	Initiated	HSBC Securities	Hold
Dec-12-22	Downgrade	Citigroup	Buy → Neutral
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-11-21	Upgrade	Argus	Hold → Buy
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy
Jul-13-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-02-20	Resumed	Deutsche Bank	Buy
May-15-20	Upgrade	Mizuho	Neutral → Buy
Apr-29-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-27-20	Upgrade	Citigroup	Neutral → Buy
Apr-27-20	Upgrade	Wolfe Research	Underperform → Peer Perform
Jan-08-20	Initiated	Wells Fargo	Overweight
Jul-16-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jun-21-19	Upgrade	Deutsche Bank	Hold → Buy
Apr-02-19	Upgrade	Jefferies	Hold → Buy
Jan-17-19	Initiated	UBS	Buy
Jan-03-19	Downgrade	BofA/Merrill	Neutral → Underperform
Dec-03-18	Downgrade	Craig Hallum	Buy → Hold
Oct-30-18	Downgrade	Argus	Buy → Hold
Oct-25-18	Downgrade	Canaccord Genuity	Buy → Hold
Oct-19-18	Resumed	BofA/Merrill	Buy
Jun-07-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
May-01-18	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-23-18	Initiated	Argus	Buy

View All

Labcorp Holdings Inc Stock (LH) Latest News

Jun 04, 2025

Should You Continue to Hold Labcorp Stock in Your Portfolio? - TradingView

Jun 04, 2025

Jun 03, 2025

Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes - Law360

Jun 03, 2025

FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit - The Malaysian Reserve

Jun 03, 2025

FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit - Morningstar

Jun 03, 2025

Jun 02, 2025

ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage - Yahoo Finance

Jun 02, 2025

May 30, 2025

Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com

May 30, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com

May 30, 2025

Labcorp Expands Oncology Portfolio to Improve Patient Care and A - GuruFocus

May 30, 2025

Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus

May 30, 2025

Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan

May 30, 2025

May 29, 2025

Labcorp Holdings Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com

May 26, 2025

May 25, 2025

Should You Buy Labcorp Holdings Inc. (NYSE:LH) For Its Upcoming Dividend? - Yahoo

May 25, 2025

May 23, 2025

Labcorp (LH) Secures $117.03M Contract Modification for Laborato - GuruFocus

May 23, 2025

May 22, 2025

Chart of the Day: LabCorp Isn't Passing the Growth Test Yet - TheStreet Pro

May 22, 2025

May 21, 2025

Mizuho lifts LabCorp stock target to $274, keeps Outperform rating By Investing.com - Investing.com Canada

May 21, 2025

Labcorp Holdings (NYSE:LH) Partners With Frame to Enhance Fertility Testing Access - Yahoo Finance

May 21, 2025

Mizuho lifts LabCorp stock target to $274, keeps Outperform rating - Investing.com

May 21, 2025

Mizuho Adjusts Price Target on Labcorp Holdings to $274 From $264, Maintains Outperform Rating - marketscreener.com

May 21, 2025

May 20, 2025